Корвалтаб Drug photo

The description is actual on 16.11.2014

  • Latin name: Corvaltab
  • ATH code: N05CB02
  • Active ingredient: Phenobarbital + ethyl ether of α-bromizovalerianovy acid + oil mint
  • Producer: LLC Farm Start, Ukraine


1 tablet includes:

  • 8,2 mg – ethyl ether of α-bromizovalerianovy acid;
  • 7,5 mg – phenobarbital;
  • 0,58 mg – mint oil.

Additional ingredients:

  • TSMK;
  • β-cyclodextrin;
  • monohydrate of lactose;
  • potato starch;
  • magnesium stearate.

Release form

Drug Korvaltab is issued in the form of tablets on 20 or 100 pieces in one packaging.

Pharmacological action

Somnolent and sedative.

Pharmacodynamics and pharmacokinetics

Tablets Korvaltab, thanks to properties of active ingredients, have the calming effect, promote lowering of excitability of TsNS and facilitate backfilling process. Spasmolytic and sedative action, like effects of extract of a valerian, is inherent in the ethyl ether of α-bromizovalerianovy acid which is Korvaltab's part which at reception of high doses, shows also not expressed somnolent action. Sedative and vazodilatiruyushchy effect of phenobarbital is shown in small doses and passes into sleeping pill, at reception of the raised doses. All this is supported with spasmolytic and reflex vasodilating influence of mint oil.

Indications to use

Indications to Korvaltab's reception are:

  • hyperexcitability;
  • neurosises with acrimony symptoms;
  • sleeplessness, and also disturbances in the course of backfilling;
  • tachycardia;
  • neurocirculatory dystonia;
  • spasm of coronary vessels (slight);
  • arterial hypertension at an early stage of development;
  • the spasms of bodies of a gastrointestinal tract provoked by disturbances of neurovegetative system.


Use of drug is contraindicated:

  • at a hepatic porphyria;
  • at hypersensitivity to ingredients of tablets Korvaltab;
  • at pathologies of a liver and kidneys in a heavy stage;
  • when feeding by a breast;
  • at pregnancy;
  • aged till 18 flyings.

Side effects

As a rule, the HP is quite well transferred by patients.

Manifestation of day drowsiness, dizziness benign, a digestive disturbance and skin allergic reactions is in certain cases possible.

These phenomena not of constant character also usually disappear when lowering a dose, the temporary termination of reception of tablets extremely seldom is required.

In case of reception of high doses throughout a long time, observed development of a bromism.

Tablets Korvaltab, application instruction

The instruction on Korvaltab recommends reception of tablets inside (orally) to food.

The selection of daily doses, as well as duration of the treatment, has to be established only by the doctor and pass individually.

As a rule, the adult (after 18 flyings) recommend to accept 1–2 tablets two or three of time (it is desirable with an identical break) for day.

In case of therapy of spasms of coronary vessels, and also a single dose it is possible to increase treatments of tachycardia to 3 tablets.


At overdose observed increase of weakness, drowsiness, and also feeling of dizziness.

The gastric lavage and symptomatic therapy is shown.


At the combined reception with other drugs, the oppressing TsNS, bilateral strengthening of effects is observed.

Effect of medicine, at joint reception with alcohol and valproic acid, increases.

Against Korvaltab's action weakening of effects of Griseofulvin, glucocorticoids, derivatives of coumarin, oral contraceptive means and increase of toxicity of the Methotrexate is possible.

Terms of sale

Korvaltab it is possible to get without presentation of the recipe.

Storage conditions

Temperature of storage of tablets should not be above 25 °C.

Period of validity

Tablets are suitable for the use for 24 months from the moment of their production.

Special instructions

During passing of therapy with Korvaltab's use driving of the car and the activity connected with speed of psychomotor reactions is not recommended.

With intolerance of lactose galactose it is better for patients not to appoint this medicine as tablets include lactose.


Coincidence on the ATH code of the 4th level:


  • Korvaltab of a tablet No. 100farmastart (Ukraine, Kiev)
  • Korvaltab of a tablet No. 20farmastart (Ukraine, Kiev)


  • Korvaltab of the tab. No. 100farmastart
  • Korvaltab of the tab. No. 100farmastart


  • Korvaltab No. 20 of table.
to show still
Section: For a nervous system Cardiological
in more detail

Education: Graduated from the Vinnytsia national medical university of N. I. Pirogov, pharmaceutical faculty, the higher pharmaceutical education – the specialty "Pharmacist".

Experience: Work in Koneks and Bios-Media pharmacy chains as "Druggist". Work as "Pharmacist" in Avicenna pharmacy chain of the city of Vinnytsia.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Korvaltab surely consult with the attending physician.